INVO Fertility's share count has roughly quintupled since December while its Q2 profit rests on a one-time gain
INVO Fertility, which operates fertility clinics and makes an intravaginal culture device, closed 57% higher on August 17 after releasing second-quarter 2026 results — results that showed a swing to net profit driven almost entirely by a one-time accounting gain, not by